The Val896Met mutation of human cardiac Myosin-Binding Protein C

(other names:  V896M)

SEQUENCE
exon 27
nucleotide change G>A
nucleotide pos. in gene 17721
UCSC Golden Path position 47314055
amino acid changeVal İLys
charge change  
codon change GTG>ATG
transcript change missense
translation change substitution


mutated amplimer sequence:
ggaagtgccccctatgtgaccagtgggcagttcagagtctagggcatgga
tctccagcttccccaggcttgctcagacccctctctgacctctcctctgc
ccaggtccccccagcgaacccacccacctggcagtagaggacgtctctga
caccacggtctccctcaagtggcggcccccagagcgcAtgggagcaggag
gcctggatggctacagcgtggagtactgcccagagggctgtgagtgtccc
cgcccccaacccccctccccaaaggaagaacatgctcaccttgccattga
gcagattcacctgtagtcaagttttttaggcccacttttgccgaaagttg
aggacacccagagaaatatctgtcctgttttcagaagtaaaaaagcttgc
ctagtgaaaaacaaatgcagagtaaagctgactgtaacacttctttgagc
agtgcga


RESTRICTION ENZYME
restriction enzyme BstU I site lost
fragment sizes, wild-type strand (bp) 271, 186
fragment sizes, mutant strand (bp) 457

 
disease none

 
    References and comments
  1. Moolman-Smook JC, De Lange WJ, Bruwer EC, Brink PA, Corfield VA.
    The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events.
    Am J Hum Genet 1999 Nov;65(5):1308-20. (PubMed:10521296)
  2. Jaaskelainen P, Kuusisto J, Miettinen R, Karkkainen P, Karkkainen S, Heikkinen S, Peltola P, Pihlajamaki J, Vauhkonen I, Laakso M.
    Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland.
    J Mol Med 2002 Jul;80(7):412-22. Epub 2002 Apr 11. (PubMed:12110947)
  3. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M.
    Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy.
    Circulation 2003 May 6;107(17):2227-32. Epub 2003 Apr 21. (PubMed:12707239)
  4. Morner S, Richard P, Kazzam E, Hellman U, Hainque B, Schwartz K, Waldenstrom A.
    Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden.
    J Mol Cell Cardiol 2003 Jul;35(7):841-9. (PubMed:12818575)
  5. Merk, Seidman et al., 2004. (this study)
  6. Van Driest SL, Vasile VC, Ommen SR, Will ML, Tajik AJ, Gersh BJ, Ackerman MJ.
    Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
    J Am Coll Cardiol 2004 Nov 2;44(9):1903-10. (PubMed:15519027)


Clinical features of individuals in this study having the MYBPC3:Val896Met mutation.
pedigree sex height (in.) weight (lb.) age of onset age at exam NYHA Class LVWT, mm. LVED LVES LA EF, % diagnosis
IF M   269   45   18 55 36   60 HCM
IF M           12 52 25 45    

Last modified: April 24, 2006